Heck Capital Advisors’s Idexx Laboratories IDXX Stock Holding History

Heck Capital Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-38	Closed	-$15.7K	–	497
2024 Q4	$15.7K	Buy	+38	New	+$16.7K	﹤0.01%	508

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Heck Capital Advisors's IDXX Position: Q1 2025 in Review

Heck Capital Advisors sold out of Idexx Laboratories (IDXX) in Q1 2025, closing a stake of 38 shares — an estimated $15.7K sold.

Heck Capital Advisors first reported a position in IDXX in Q4 2024 and held it in 1 quarter. The position peaked at $15.7K in Q4 2024. 1,144 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.

Heck Capital Advisors reported no remaining Idexx Laboratories position as of Q1 2025 after selling out during the quarter.
Heck Capital Advisors sold 38 Idexx Laboratories shares in Q1 2025, an estimated $15.7K.
Heck Capital Advisors first reported a position in Idexx Laboratories in Q4 2024 and held it in 1 quarter.
Heck Capital Advisors's Idexx Laboratories position peaked at $15.7K in Q4 2024.
1,144 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.

Based on Heck Capital Advisors's 13F filing for Q1 2025, filed 13 May 2025.